Symbol Name ID |
Pmm2
phosphomannomutase 2 MGI:1859214 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Intracranial hemorrhage |
Dandy-Walker malformation |
Microcephaly |
Stroke-like episode |
Elevated circulating growth hormone concentration |
Increased circulating prolactin concentration |
Delayed myelination |
Olivopontocerebellar hypoplasia |
Dilated fourth ventricle |
Cerebellar vermis hypoplasia |
Cerebellar hypoplasia |
Cerebellar atrophy |
Abnormality of coordination |
Ataxia |
Dysmetria |
Tremor |
Intention tremor |
Delayed speech and language development |
Dysarthria |
Intellectual disability |
Hyperreflexia |
Areflexia |
Hyporeflexia |
Global developmental delay |
Peripheral neuropathy |
Polyneuropathy |
Seizure |
Generalized-onset seizure |
Disease(s) Associated with PMM2 | ||||||||||||||||||||||||||||
congenital disorder of glycosylation Ia |
Mouse Phenotypes | nervous system phenotype |
abnormal embryonic neuroepithelium morphology |
|
Availability | Mouse Genotype | ||
Pmm2tm1.1Cknr/Pmm2tm2.1Cknr | |||
Pmm2tm1.1Jins/Pmm2tm2.1Jins | * |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|